Increased stroke risk at 30-days post-CABG versus PCI

Increased stroke risk at 30-days post-CABG versus PCI
The risk of stroke at 30 days is significantly higher in patients who undergo coronary revascularization with coronary artery bypass graft surgery compared to those who undergo percutaneous coronary intervention, according to research published in the Aug. 28 issue of the Journal of the American College of Cardiology.

(HealthDay) -- The risk of stroke at 30 days is significantly higher in patients who undergo coronary revascularization with coronary artery bypass graft (CABG) surgery compared to those who undergo percutaneous coronary intervention (PCI), according to research published in the Aug. 28 issue of the Journal of the American College of Cardiology.

Tullio Palmerini, M.D., from Policlinico S. Orsola in Bologna, Italy, and colleagues conducted a meta-analysis of 19 trials that included 10,944 patients who were randomized to CABG or PCI.

The researchers found the 30-day rate of stroke to be significantly increased after CABG compared with PCI (1.20 versus 0.34 percent; odds ratio [OR], 2.94). After a median follow-up of 12.1 months, the results were similar (1.83 versus 0.99 percent; OR, 1.67). The relative increase in the risk of stroke observed with CABG compared with PCI at either 30 days or midterm follow-up was not affected by the extent of coronary artery disease (single vessel versus multivessel versus left main). When the outcomes of 33,980 patients from 27 observational studies were analyzed, the results were also similar.

"Coronary revascularization by CABG compared with PCI is associated with an increased risk of stroke at 30 days and at the midterm follow-up," the authors write.

Two authors disclosed financial ties to pharmaceutical companies.

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Adrenal sex hormone level may predict heart disease risk

Oct 30, 2014

(HealthDay)—Blood levels of the adrenal sex hormone dehydroepiandrosterone (DHEA) and its sulfate (DHEA-S) may predict an increased risk of coronary heart disease (CHD) in elderly men, according to a study ...

Researchers aim to simplify life saving drug

Oct 29, 2014

Heparin, the life saving blood thinner used in major surgeries and treatment of heart diseases, is a complicated drug but a research team from the University of British Columbia has set out to make its use a lot safer by ...

Frequent readmissions, high costs after cardiac arrest

Oct 29, 2014

(HealthDay)—Frequent readmissions and high inpatient costs are seen among older survivors of in-hospital cardiac arrest, according to a study published online Oct. 28 in Circulation: Cardiovascular Quality an ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.